Literature DB >> 11200077

Survivin gene expression and prognosis in recurrent colorectal cancer.

M Miller, D Smith, A Windsor, A Kessling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11200077      PMCID： PMC1728169          DOI： 10.1136/gut.48.1.137

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  6 in total

Review 1.  Cellular immunotherapy for soft tissue sarcomas.

Authors:  Steven Eric Finkelstein; Mayer Fishman; Anthony P Conley; Dmitry Gabrilovich; Scott Antonia; Alberto Chiappori
Journal:  Immunotherapy       Date:  2012-03       Impact factor: 4.196

2.  Therapeutic effects of survivin dominant negative mutant in a mouse model of prostate cancer.

Authors:  Li Pan; Xing-Chen Peng; Fei Leng; Qing-Zhong Yuan; Yan Shan; Dan-Dan Yu; Zhi-Yong Li; Xiang Chen; Wen-Jing Xiao; Yuan Wen; Tian-Tai Ma; Li Yang; Yong-Qiu Mao; Han-Shuo Yang; Yu-Quan Wei; Chun-Ting Wang
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-09       Impact factor: 4.553

3.  Expression of survivin and caspase-3 in gastric cancer.

Authors:  J Kania; S J Konturek; K Marlicz; E G Hahn; P C Konturek
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

4.  Tumor-specific gene expression using the survivin promoter is further increased by hypoxia.

Authors:  L Yang; Z Cao; F Li; D E Post; E G Van Meir; H Zhong; W C Wood
Journal:  Gene Ther       Date:  2004-08       Impact factor: 5.250

5.  Transforming growth factor-β suppresses metastasis in a subset of human colon carcinoma cells.

Authors:  Neka A K Simms; Ashwani Rajput; Elizabeth A Sharratt; Melanie Ongchin; Carol A Teggart; Jing Wang; Michael G Brattain
Journal:  BMC Cancer       Date:  2012-06-06       Impact factor: 4.430

6.  Efficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34-->Ala mutant.

Authors:  Xing-Chen Peng; Li Yang; Li-Ping Yang; Yong-Qiu Mao; Han-Shuo Yang; Ji-Yan Liu; Dong-Mei Zhang; Li-Juan Chen; Yu-Quan Wei
Journal:  J Exp Clin Cancer Res       Date:  2008-09-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.